Gene Therapy

MeiraGTx announces data from Phase 1/2 clinical study of gene therapy for patients with X-linked retinitis pigmentosa

According to the company, the primary outcome of the MGT009 study is safety, and botaretigene sparoparvovec treatment was found to be generally safe and well-tolerated.

Foundation Fighting Blindness announces leadership changes

Jason Menzo is named CEO, while Russell Kelley, PhD, MBA, will become managing director of the RD Fund. Ben Yerxa, PhD, will take the helm of Opus Genetics, the first RD Fund- and foundation-backed spin-off company.

Australian scientists conduct stem cell research unveiling a detailed genetic roadmap of glaucoma

The research is the result of a national collaboration led by investigators from the Centre for Eye Research Australia at the University of Melbourne and University of Tasmania and the Garvan Institute of Medical Research.

Study: Investigators make key discovery in AMD

June 06, 2022

According to the study by a team of researchers from the University of California Irvine and University of Southern California, treatment with Humanin G reduced protein levels of inflammation markers that become elevated in age-related macular degeneration.